MONDAY, MAY 22, 2017

Drug-resistant TB a danger to disease elimination

Justine Greening, the United Kingdom's international development secretary, has stated that drug-resistant tuberculosis (TB) is a disease that threatens to endanger all of the progress that researchers have made toward eliminating TB over the past several decades. Read More »

NIH researchers link red blood cell traits, malaria risk in children

Researchers with the National Institute of Allergy and Infectious Diseases, a branch of the National Institutes of Health (NIH), have identified specific traits of red blood cells in children that determine the risk of the children contracting malaria. Read More »

GSK makes academic partnerships in U.S., Canada and Europe

GSK has created the 2015 Discovery Fast Track Challenge and partnered with academics from the U.S., Canada and Europe to inspire faster transitions from early-stage research to novel medicines. Read More »

Dr. Gary Michelson to receive Albert B. Sabin Humanitarian Award

Renowned physician being honored for work toward eliminating neglected tropical diseases. Read More »

Zimbabwe faces potential cholera outbreak

Zimbabwe towns that border Mozambique have reported 14 cholera infections as health officials consider how to handle this health threat more effectively than the 2008-09 epidemic.  Read More »

Researchers test first Ebola vaccine in infected community

World Health Organization (WHO) and Guinean government officials have launched the first trial of a vaccine for Ebola in Basse-Guinee, a community affected by the virus during the past year. Read More »

Infant immune systems may strengthen with HPV exposure

A recent Duke-National University of Singapore (NUS) study suggests that exposing infants’ immune systems to Hepatitis B Virus Infection (HBV) increases the maturity of infants’ immune systems, potentially increasing the chances of infants surviving bacterial infections throughout early life. Read More »

Kaprielian named HHS director for New England states

Health and Human Services (HHS) Secretary Sylvia Burwell recently announced that Rachel Kaprielian will be HHS’s new Region I director for Vermont, Maine, Connecticut, New Hampshire, Massachusetts and Rhode Island. Read More »

Malaria cells release scents to attract mosquitoes

Scientists from Washington University of Medicine in St. Louis have discovered that Plasmodium falciparum, the parasite that causes malaria, releases odors that are attractive to mosquitoes. Read More »

Louisiana reduces TB rate by more than 50 percent

Health professionals have reduced the state of Louisiana's tuberculosis (TB) rate by more than half between 2010 and 2014. Read More »

FDA approves Quadracel DTaP-IPV vaccine

Immunization protects children from poliomyelitis, pertussis, diphtheria and tetanus. Read More »

Gene-editing technique may reduce, eliminate mosquito-borne disease

Researchers recently mastered a gene-editing technique that may help them to eliminate mosquito diseases around the world. Read More »

Human immune system’s unique method of fighting TB

A novel tissue culture model illustrates how a body with a latent tuberculosis (TB) infection does not contract active TB because its immune system takes a vital preventative step. Read More »

NIH study finds Ebola mutations not an issue in West Africa

Virus in current outbreak is no more contagious or severe Read More »

Flu cases exceed record highs in Delaware

Delaware laboratory records confirm the state has experienced an all-time high in flu cases for the 2014-2015 flu season, passing even the outbreak of H1N1 (swine flu) in 2009-10. Read More »

Novel antiviral compounds fight wide range of viruses

Kineta, Inc., a biotechnology company that creates immune modulating drugs, recently released data from its studies that show its new antiviral compounds prevent subjects from contracting a broad range of viruses, like Ebola, that are both current and emerging. Read More »

Valneva to test vaccine prototype in Japan

Valneva SE, a biotechnology company developing pure play vaccines, recently announced that its Chemo-Sero-Therapeutic Research Institute has approval to produce and market an influenza vaccine prototype to help Japan be better protected against pandemics. Read More »

Positive results reported from Ebola vaccine trial in Liberia

Researchers recently announced that they have had positive results from two experimental Ebola vaccines in their Phase 2 clinical trial in Liberia, and the vaccine is considered safe enough to continue to Phase 3 of testing. Read More »

Florida confirms measles case

International traveler with virus visited Osceola, Orange, Miami-Dad and Sarasota counties. Read More »

Genetic mutations can help prevent flu deaths

Rockefeller University researchers have discovered that a rare genetic mutation is the reason that some people die from influenza while others recover quickly. Read More »